Home > Financial Ratios > VENUS REMEDIES

VENUS REMEDIES
EBIT Growth

    Back to All Ratios
VENUS REMEDIES is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for VENUS REMEDIES
Please provide your vote to see the results

VENUS REMEDIES Last 5 Year EBIT Growth History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   EBIT Growth(%) 17.583.14-40.091,061.31222.71

What is the latest EBIT Growth ratio of VENUS REMEDIES ?

The latest EBIT Growth ratio of VENUS REMEDIES is 17.58 based on Mar2024 Consolidated results.
Year EBIT Growth
Mar202417.58
Mar20233.14
Mar2022-40.09
Mar20211,061.31
Mar2020222.71

How is EBIT Growth of VENUS REMEDIES Trending?

Years EBIT Growth % Change
Mar2024 17.58
459.87
Mar2023 3.14
Positive
Mar2022 -40.09
Negative
Mar2021 1061.31
376.54
Mar2020 222.71 -

Other Financial Ratios of VENUS REMEDIES


Compare EBIT Growth ratio of peers of VENUS REMEDIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
VENUS REMEDIES ₹412.1 Cr -2.7% 4% -13.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹402,608.0 Cr -3.9% -6.7% 11.2% Stock Analytics
DIVIS LABORATORIES ₹157,383.0 Cr -1.4% 1.8% 56.7% Stock Analytics
CIPLA ₹118,239.0 Cr -0.6% 1.7% 0.8% Stock Analytics
DR REDDYS LABORATORIES ₹97,187.7 Cr -4.8% -10.2% -6.6% Stock Analytics
ZYDUS LIFESCIENCES ₹89,695.7 Cr -5.4% -8.9% 0.6% Stock Analytics


VENUS REMEDIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
VENUS REMEDIES

-2.7%

4%

-13.2%

SENSEX

-0.3%

0.1%

4.9%


You may also like the below Video Courses